Related Experiment Videos
Microbiological profile of teicoplanin
1Department of Cellular and Molecular Biology and Pathology, II Medical School, University of Naples, Italy.
Journal of Chemotherapy (Florence, Italy)
|January 1, 1991
Summary
Teicoplanin, a novel glycopeptide antibiotic, demonstrates potent in-vitro antibacterial activity against gram-positive anaerobic bacteria. It exhibits superior efficacy compared to other widely used antibiotics in clinical settings.
Area of Science:
- Microbiology
- Pharmacology
Background:
- Gram-positive anaerobic bacterial infections pose significant clinical challenges.
- Existing antibiotic treatments have limitations in efficacy and resistance development.
Purpose of the Study:
- To evaluate the in-vitro antibacterial activity of teicoplanin against clinically isolated gram-positive anaerobic bacteria.
- To compare teicoplanin's efficacy with established antibiotics.
Main Methods:
- Testing teicoplanin against 258 clinical isolates of gram-positive anaerobic bacteria.
- Determining minimum inhibitory concentrations (MICs).
- Comparative analysis with clindamycin, rifampicin, netilmicin, enoxacin, and vancomycin.
Main Results:
- Teicoplanin exhibited high antibacterial activity across all tested strains.
- Geometric mean MICs, MIC 50, and MIC 90 were 0.125, 0.12, and 0.5 microg/ml, respectively.
- Teicoplanin demonstrated superior activity compared to the other evaluated antibiotics.
Conclusions:
- Teicoplanin is a highly effective antibiotic against gram-positive anaerobic bacteria.
- Its potent in-vitro activity suggests potential as a valuable therapeutic agent.